Clinical Trial Update: Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia [Phase 3]

View source ↗

Summary

Phase 3 trial of taurolidine lock solution to prevent catheter-related bacteremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Neoplasms

Drugs mentioned

• taurolidine lock solution (taurolidine)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Bacteremia, Neoplasms | Phase 3 | Status: COMPLETED